Trials of CCBs

January 1998
CMAJ: Canadian Medical Association Journal;01/13/98, Vol. 158 Issue 1, p21
Academic Journal
No abstract available.


Related Articles

  • Calcium channel blockers: do they have pleiotropic effects on atherosclerosis? Perez, IF Soltero // Journal of Human Hypertension;Apr2000 Supplement, Vol. 14 Issue 4, pS96 

    Since 1980, calcium channel blockers (CCBs) have been used effectively to lower high blood pressure (HBP). Flekestein proposed that CCBs could be used to avoid calcium deposition on the arterial wall, one of the main components of atherosclerosis. This is also called ectopic calcium. This review...

  • CCBs. Gaeta, Lois A. // Drug Topics;11/4/96, Vol. 140 Issue 21, p79 

    Presents information on safety and efficacy of calcium-channel blockers (CCBs) based on the `Prospective Randomized Amlodipine Survival Evaluation (PRAISE)' study. Benefits of amlopidine on patients with normal coronary arteries; Clarification of reports stating that CCBs increased the risk of...

  • Study backs preventive use of long-acting CCBs. James, Laura // GP: General Practitioner;4/17/2009, p13 

    The article reports on the randomised controlled trials of long-acting calcium-channel blockers (CCBs) in patients with coronary artery disease conducted between 1966 and 2008. Researchers from the Columbia University College of Physicians and Surgeons have demonstrated that long-acting CCBs can...

  • Effect of calcium channel blockers on incidence of diabetes: a meta-analysis. Hiroshi Noto; Atsushi Goto; Tetsuro Tsujimoto; Mitsuhiko Noda // Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy;2013, Vol. 6, p257 

    Aims: Insulin resistance and the progressive loss of β-cell function are components of the fundamental pathophysiology of type II diabetes. A recent experimental study suggested that calcium channel blockers (CCBs) might inhibit β-cell apoptosis, enhance β-cell function, and prevent...

  • Calcium Channel Blockers in Cardiovascular Pharmacotherapy. Godfraind, Theophile // Journal of Cardiovascular Pharmacology & Therapeutics;Nov2014, Vol. 19 Issue 6, p501 

    This paper summarizes the pharmacological properties of calcium channel blockers (CCBs), their established therapeutic uses for cardiovascular disorders and the current improvement of their clinical effects through drug combinations. Their identification resulted from study of small molecules...

  • MMD refutes CCB data.  // Drug Topics;3/20/95, Vol. 139 Issue 6, p8 

    Reports on Marion Merrel Dow's (MMD) issuance of a statement countering the charges that calcium-channel blockers (CCBs) increase the risk of heart attack. MMD's assertion that its clinical trials for Cardizem gave no evidence of it being a risk factor for myocardial infarction.

  • New ALLHAT findings: Diuretic most effective antihypertensive for preventing heart failure.  // Formulary;Jul2006, Vol. 41 Issue 7, p346 

    The article discusses a follow-up analysis of a large clinical trial on hypertension which suggests that diuretics are superior to both calcium channel blockers (CCBs) and, at least in the short term, angiotensin-converting enzyme (ACE) inhibitors in preventing heart failure (HF) in hypertensive...

  • Effects of T-Type Calcium Channel Blockers on Renal Function and Aldosterone in Patients with Hypertension: A Systematic Review and Meta-Analysis. Li, Xue; Yang, Mao Sheng // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    Background: High blood pressure can cause kidney damage, which can increase blood pressure, leading to a vicious cycle. It is not clear whether the protective effects of T-type calcium channel blockers (T-type CCBs) on renal function are better than those of L-type CCBs or renin-angiotensin...

  • Calcium channel blockade to prevent stroke in hypertension: A meta-analysis of 13 studies with 103,793 subjects. Angeli, Fabio; Verdecchia, Paolo; Reboldi, Gian Paolo; Gattobigio, Roberto; Bentivoglio, Maurizio; Staessen, Jan A.; Porcellati, Carlo // American Journal of Hypertension;Sep2004, Vol. 17 Issue 9, p817 

    The possibility that specific antihypertensive treatments may prevent the occurrence of stroke more effectively than other treatments remains unproved. We undertook a meta-analysis to assess whether calcium channel blockers (CCBs) are associated with a lesser risk of stroke as compared with...

  • The Effects of Calcium Channel Blockers in the Prevention of Stroke in Adults with Hypertension: A Meta-Analysis of Data from 273,543 Participants in 31 Randomized Controlled Trials Chen, Gui Jv; Yang, Mao Sheng // PLoS Clinical Trials;Mar2013, Vol. 8 Issue 3, p1 

    Background: Hypertension is a major risk factor for the development of stroke. It is well known that lowering blood pressure decreases the risk of stroke in people with moderate to severe hypertension. However, the specific effects of calcium channel blockers (CCBs) against stroke in patients...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics